胸肌前与胸肌下乳房再造配对分析:术后并发症率差异
该回顾性配对研究比较了胸肌前与双平面胸肌下组织扩张器置入的术后并发症,共纳入80例患者(138侧乳房再造),两组各40例,按年龄、体重指数、放疗史及脱细胞真皮基质类型匹配。结果显示总并发症率(p=0.356)和乳房切除皮瓣坏死率(p=1.0)无差异,主要并发症(p=0.06)、主要感染(p=0.09)和再造失败(p=0.09)的差异未达显著性。
要点
- 胸肌前组围手术期抗生素预防不足24小时,胸肌下组至少1周。
- 总并发症率与皮瓣坏死率在两组间无显著差异。
- 主要并发症、感染和再造失败差异未达统计学显著性。
核心结论
- 即刻胸肌前组织扩张器置入联合前侧脱细胞真皮基质覆盖及不足24小时抗生素预防是安全的,与胸肌下置入联合下侧脱细胞真皮基质吊带及延长抗生素疗程相比结果不劣。
研究设计与样本
- 回顾性配对研究,纳入80例患者(138侧乳房再造),胸肌前组40例,双平面胸肌下组40例。
- 两组按年龄、体重指数、放疗史和脱细胞真皮基质类型进行匹配。
- 证据等级为治疗性III级。
主要发现
- 总术后并发症率两组无差异(p=0.356)。
- 乳房切除皮瓣坏死率两组无差异(p=1.0)。
- 主要并发症(p=0.06)、主要感染(p=0.09)和再造失败(p=0.09)的观察差异未达显著性。
关键数值与推荐
- 胸肌前组围手术期抗生素预防不足24小时,胸肌下组至少1周。
- 胸肌前组采用前侧脱细胞真皮基质覆盖,胸肌下组采用下侧脱细胞真皮基质吊带。
临床怎么用
- 胸肌前组织扩张器置入可考虑缩短抗生素预防至不足24小时,但需结合患者个体情况。
- 胸肌前与胸肌下再造的并发症风险总体相当,选择术式时可综合软组织覆盖等因素。
局限性
- 回顾性研究设计。
- 样本量较小(80例患者,138侧乳房再造)。
- 两组抗生素预防时长不同,可能影响感染相关结果解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The development of acellular dermal matrices has revolutionized implant-based breast reconstruction. The most recent development has been the introduction of prepectoral breast reconstruction. However, concerns have been expressed related to the quality of soft-tissue coverage and infectious complications. Thus, the authors felt it prudent to perform a matched-pair analysis of clinical outcomes following prepectoral and subpectoral tissue expander placement. METHODS: A retrospective study of patients who underwent immediate breast reconstruction by means of prepectoral (group 1) and dual-plane subpectoral (group 2) tissue expander placement was performed. Patients in each group were matched for age, body mass index, history of radiotherapy, and type of acellular dermal matrix. Of note, patients in group 1 received perioperative antibiotic prophylaxis for less than 24 hours, whereas patients in group 2 received antibiotic prophylaxis for at least 1 week. RESULTS: A total of 80 patients (138 breast reconstructions) were included in the study (group 1, n = 40; group 2, n = 40). No difference in total postoperative complication rate (p = 0.356) and mastectomy skin necrosis rate (p = 1.0) was noted. Observed differences in major complications (p = 0.06), major infection (p = 0.09), and loss of reconstruction (p = 0.09) were not found to be significant. CONCLUSION: Immediate prepectoral tissue expander insertion with anterior acellular dermal matrix coverage and less than 24 hours of antibiotic prophylaxis is safe and compares favorably to subpectoral tissue expander placement with an inferior acellular dermal matrix sling and a prolonged course of antibiotics. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
引用
- Momeni A, Remington AC, Wan DC, et al. A Matched-Pair Analysis of Prepectoral with Subpectoral Breast Reconstruction: Is There a Difference in Postoperative Complication Rate? Plast Reconstr Surg. 2019. PMID: 31568276. doi:10.1097/PRS.0000000000006008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。